X
GO

Opioid Information and Medication Assisted Treatment 

Opioid Overdose Recognition and Response Brochure


Iowa Opioid State Targeted Response (STR) 

STR is a two-year, SAMHSA-supported, initiative to expand and enhance opioid use disorder prevention and treatment services across Iowa.

The purpose is to build community capacity for a successful community response to the opioid crisis through the following goals:

  • Build an enhanced, statewide infrastructure to address opioid misuse in Iowa
  • Increase awareness of opioid risks through statewide prevention efforts
  • Increase the use of medication assisted treatment and other evidence-based practices in Iowa

Click on each of the following to access the documents: Iowa's program fact sheet, statewide STR Needs Assessment, assessment data maps and STR Strategic Plan.

For treatment resources, please click on the Opioid Treatment Programs or Providers tabs to the left. 

Medication Assisted Treatment for Prescription Drug and Opioid Addiction (MAT-PDOA)

MAT-PDOA is a three-year, SAMHSA-supported, initiative to expand and enhance substance use disorder treatment services across Iowa.

The purpose is to provide a broad array of best practices including Medication Assisted Treatment (MAT) for prescription drug and opioid use disorder treatment and integrated care services in four Iowa counties with the demonstrated need for enhancement and expansion of opioid treatment services. This grant includes support for project-specific recovery support services,including medications, medical consultation, and care coordination. Organizations will implement and follow MAT best practices and will leverage funding for related services such as counseling and additional recovery support services through other IDPH-funded sources such as Access to Recovery and the Substance Abuse Prevention and Treatment Block Grant. Organizations will offer a selection of MAT medications from the list below:

  • Methadone
  • Acamprosate (Campral)
  • Buprenorphine (Suboxone, etc)
  • Naltrexone (Revia, Depade, Vivitrol)
  • Disulfiram (Antabuse)

MAT-PDOA Report: Year Two mid-year Evaluation

MAT-PDOA Report: Year One MAT Grant Evaluation

Find an Iowa MAT provider: Open map in a new window (tab)